A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis DOI Creative Commons
Junyue Xing, Xiaohan Ma,

Yanan Yu

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 28, 2024

Abstract Doxorubicin (DOX), a potent antineoplastic agent, is commonly associated with cardiotoxicity, necessitating the development of strategies to reduce its adverse effects on cardiac function. Previous research has demonstrated strong correlation between DOX‐induced cardiotoxicity and activation oxidative stress pathways. This work introduces novel antioxidant therapeutic approach, utilizing libraries tannic acid N‐acetyl‐L‐cysteine‐protected bimetallic cluster nanozymes. Through extensive screening for antioxidative enzyme‐like activity, an optimal nanozyme (AuRu) identified that possess remarkable characteristics, mimicking catalase‐like enzymes. Theoretical calculations reveal surface interactions prepared nanozymes simulate hydrogen peroxide decomposition process, showing these readily undergo OH⁻ adsorption O₂ desorption. To enhance targeting, atrial natriuretic peptide conjugated AuRu nanozyme. These cardiac‐targeted nanozymes, their anchoring capability, effectively cardiomyocyte ferroptosis PANoptosis without compromising tumor treatment efficacy. Thus, approach demonstrates significant reductions in chemotherapy‐induced cell death improvements function, accompanied by exceptional vivo biocompatibility stability. study presents promising avenue preventing offering potential clinical benefits cancer patients.

Language: Английский

Nanozymes for nanohealthcare DOI
Yihong Zhang, Gen Wei, W. Liu

et al.

Nature Reviews Methods Primers, Journal Year: 2024, Volume and Issue: 4(1)

Published: May 30, 2024

Language: Английский

Citations

79

Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next‐Generation Therapeutics DOI
Namrata Singh,

G. R. Sherin,

Govindasamy Mugesh

et al.

Angewandte Chemie International Edition, Journal Year: 2023, Volume and Issue: 62(33)

Published: April 21, 2023

Nanozymes, nanomaterials with enzyme-mimicking activity, have attracted tremendous interest in recent years owing to their ability replace natural enzymes various biomedical applications, such as biosensing, therapeutics, drug delivery, and bioimaging. In particular, the nanozymes capable of regulating cellular redox status by mimicking antioxidant mammalian cells are great therapeutic significance oxidative-stress-mediated disorders. As distinction physiological oxidative stress (oxidative eustress) pathological distress) occurs at a fine borderline, it is challenge design that can differentially sense two extremes cells, tissues organs mediate appropriate chemical reactions. this Review, we summarize advances development redox-active applications. We primarily highlight prooxidant disease model systems, cancer, neurodegeneration, cardiovascular diseases. The future perspectives emerging area research challenges associated applications described.

Language: Английский

Citations

61

Recent advances in multi‐metallic‐based nanozymes for enhanced catalytic cancer therapy DOI Creative Commons
Mingjin Cui, Bo Xu, Lianhui Wang

et al.

BMEMat, Journal Year: 2023, Volume and Issue: unknown

Published: Sept. 19, 2023

Abstract Nanozymes have emerged as a promising alternative to natural enzymes, effectively addressing enzymes' inherent limitation. Versatility and potential applications of nanozyme span across various fields, with catalytic tumor therapy being one prominent area. This has sparked significant interest exploration in the utilization nanozymes for targeted cancer treatment. Recent advancements interdisciplinary research, nanotechnology, biotechnology, technology led emergence multi‐metallic‐based nanozymes, which exhibit tremendous further development. review focuses on investigating synergistic effects aiming enhance our understanding their activities facilitate broader applications. We comprehensively survey remarkable achievements synthesis, mechanisms, latest therapy. Furthermore, we identify current limitations prospects development new materials application novel technologies, along challenges associated underscores significance emphasizes need continued well impact realization breakthroughs

Language: Английский

Citations

50

Fe/N-doped carbon dots-based nanozyme with super peroxidase activity, high biocompatibility and antibiofilm ability for food preservation DOI

Fangchao Cui,

Lanling Li,

Dangfeng Wang

et al.

Chemical Engineering Journal, Journal Year: 2023, Volume and Issue: 473, P. 145291 - 145291

Published: Aug. 7, 2023

Language: Английский

Citations

46

Nanozyme enabled protective therapy for neurological diseases DOI

F. C. Cheng,

Sumasri Kotha,

Miao Fu

et al.

Nano Today, Journal Year: 2024, Volume and Issue: 54, P. 102142 - 102142

Published: Jan. 3, 2024

Language: Английский

Citations

31

Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles DOI Creative Commons
Shi Wang, Hongliang He, Yu Mao

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: 11(17)

Published: Feb. 17, 2024

Abstract Atherosclerosis, a multifaceted chronic inflammatory disease, has profound impact on cardiovascular health. However, the critical limitations of atherosclerosis management include delayed detection advanced stages, intricate assessment plaque stability, and absence efficacious therapeutic strategies. Nanotheranostic based nanotechnology offers novel paradigm for addressing these challenges by amalgamating imaging capabilities with targeted interventions. Meanwhile, iron oxide nanoparticles have emerged as compelling candidates theranostic applications in due to their magnetic resonance capability biosafety. This review delineates current state prospects nanoparticle‐based nanotheranostics realm atherosclerosis, including pivotal aspects development, pertinent targeting strategies involved disease pathogenesis, diagnostic roles nanoparticles. Furthermore, this provides comprehensive overview nanomedicine approaches employing nanoparticles, encompassing chemical therapy, physical stimulation biological therapy. Finally, proposes discusses associated translating innovative into clinically viable anti‐atherosclerosis In conclusion, new insights future theranostic, showcasing remarkable potential oxide‐based versatile tools battle against atherosclerosis.

Language: Английский

Citations

20

Nanozyme-based strategies for efficient theranostics of brain diseases DOI
Ran Xu, Sijie Zhang, Peixia Wang

et al.

Coordination Chemistry Reviews, Journal Year: 2023, Volume and Issue: 501, P. 215519 - 215519

Published: Dec. 1, 2023

Language: Английский

Citations

43

Biomedical applications of cerium vanadate nanoparticles: a review DOI
Bahareh Farasati Far,

Reza Maleki-baladi,

Sonia Fathi‐karkan

et al.

Journal of Materials Chemistry B, Journal Year: 2023, Volume and Issue: 12(3), P. 609 - 636

Published: Dec. 11, 2023

Cerium vanadate nanoparticles (CeVO

Language: Английский

Citations

29

Catalytic Bioswitch of Platinum Nanozymes: Mechanistic Insights of Reactive Oxygen Species Scavenging in the Neurovascular Unit DOI Creative Commons

Giulia Tarricone,

Valentina Castagnola, Valentina Mastronardi

et al.

Nano Letters, Journal Year: 2023, Volume and Issue: 23(10), P. 4660 - 4668

Published: May 8, 2023

Oxidative stress is known to be the cause of several neurovascular diseases, including neurodegenerative disorders, since increase reactive oxygen species (ROS) levels can lead cellular damage, blood-brain barrier leaking, and inflammatory pathways. Herein, we demonstrate therapeutic potential 5 nm platinum nanoparticles (PtNPs) effectively scavenge ROS in different models unit. We investigated mechanism underlying PtNP biological activities, analyzing influence evolving environment during particle trafficking disclosing a key role protein corona, which elicited an effective switch-off catalytic properties, promoting their selective

Language: Английский

Citations

25

A bimetallic peroxidase-mimicking nanozyme with antifouling property for construction of sensor array to identify phosphoproteins and diagnose cancers DOI
Han Lv, Xinxin Ma, Guofang Zhang

et al.

Biosensors and Bioelectronics, Journal Year: 2024, Volume and Issue: 258, P. 116370 - 116370

Published: May 6, 2024

Language: Английский

Citations

17